| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.095 | 0.1 |